BC Platforms AG

Discover if your new anti-cancer drug will work! Our validated platform uses intact patients tumors, maintains their complexity and cellular component, and overcomes organoids. This allows to reliably assess at the pre-clinical stage the efficacy of drugs in patients.

Juvion Life Sciences develops therapeutics to prevent age-related decline in mobility and delay the onset of sarcopenia by stabilizing neuromuscular junctions (NMJs), which connect neurons and muscles.